Clinical Leader Announces Novotech a 2021 CRO Leadership Award Winner

Clinical Leader and Life Science Leader, working with Industry Standard Research (ISR), have selected Novotech for a CRO Leadership Award.

The award recognizes a CRO that meets or exceed their customer’s expectations.

Novotech was selected for this prestigious award for Compatibility in the Small and Medium Biopharma category. 

The main attributes for consideration of a CRO Leadership Award in Compatibility are:

  • Easy to work with
  • Responsiveness
  • Timely project communications

The award process involves Clinical Leader and Life Science Leader working with Industry Standard Research (ISR) to assess 60 contract research organizations (CROs) on 20+ performance metrics via ISR’s annual CRO Quality Benchmarking survey.

Survey participants were recruited from pharma and biopharma companies of all sizes and based on their decision-making influence related to working with CROs.

Respondents only evaluated companies with which they have worked on an outsourced project within the past 18 months. This level of qualification ensured that survey responses are based on actual involvement with CROs and clear experiential data.

"Selecting the right CRO can make or break your project, says Ed Miseta, Chief Editor for Clinical Leader. 

"It can lead to a successful regulatory submission and approval or cost you a lot of time and effort on a failed study. That makes CRO selection a stressful decision for any clinical operations manager. Regardless of whether you are concerned about compatibility, capabilities, expertise, quality, or reliability. We believe our CRO Leadership Awards will help managers with their search process and hopefully help to connect them with the right contract partner. We are grateful to our colleagues at Industry Standard Research (ISR) for conducting the research necessary to produce these awards. These award winners have proven themselves to be the top service providers in each category. I congratulate all of them for work ethic they exhibit in consistently meeting the needs of their drug development clients.”

Kevin Olson, CEO of Industry Standard Research said:

“Industry Standard Research continues to consider it an honor to provide the primary market research data for Life Science Leader and Clinical Leader’s CRO Leadership Awards. ISR’s stringent screening processes ensures that only highly qualified industry decision-makers participate in our CRO benchmarking market research. This is paramount as we ask the research participants to provide experiential, not perceptual, feedback on their involvement with contract suppliers over the past 18 months. The data enables users of ISR’s market research to make confident business decisions based on the experiences of their industry peers.”

기타 관련 콘텐츠